5-amino-N-[1-(3,4-dihydro-2H-chromen-8-ylsulfonyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;(5-amino-3,4-dimethylthieno[2,3-c]pyridazin-6-yl)-[3-fluoro-3-(3-methylphenyl)azetidin-1-yl]methanone;5-amino-N-[1-(2-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(3-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxybenzoyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxyphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[(2-methoxypyrimidin-5-yl)methyl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide
C132H140F3N35O20S11 — CID 158082796
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-amino-N-[1-(3,4-dihydro-2H-chromen-8-ylsulfonyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;(5-amino-3,4-dimethylthieno[2,3-c]pyridazin-6-yl)-[3-fluoro-3-(3-methylphenyl)azetidin-1-yl]methanone;5-amino-N-[1-(2-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(3-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxybenzoyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxyphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[(2-methoxypyrimidin-5-yl)methyl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide
5-amino-N-[1-(3,4-dihydro-2H-chromen-8-ylsulfonyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;(5-amino-3,4-dimethylthieno[2,3-c]pyridazin-6-yl)-[3-fluoro-3-(3-methylphenyl)azetidin-1-yl]methanone;5-amino-N-[1-(2-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(3-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxybenzoyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxyphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[(2-methoxypyrimidin-5-yl)methyl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide (PubChem CID 158082796) has the molecular formula C132H140F3N35O20S11 and a molecular weight of 2946.53 g/mol. Its IUPAC name is 5-amino-N-[1-(3,4-dihydro-2H-chromen-8-ylsulfonyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;(5-amino-3,4-dimethylthieno[2,3-c]pyridazin-6-yl)-[3-fluoro-3-(3-methylphenyl)azetidin-1-yl]methanone;5-amino-N-[1-(2-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(3-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxybenzoyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxyphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[(2-methoxypyrimidin-5-yl)methyl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide.
Molecular Properties
| Compound Name | 5-amino-N-[1-(3,4-dihydro-2H-chromen-8-ylsulfonyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;(5-amino-3,4-dimethylthieno[2,3-c]pyridazin-6-yl)-[3-fluoro-3-(3-methylphenyl)azetidin-1-yl]methanone;5-amino-N-[1-(2-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(3-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxybenzoyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxyphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[(2-methoxypyrimidin-5-yl)methyl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide |
|---|---|
| PubChem CID | 158082796 |
| Molecular Formula | C132H140F3N35O20S11 |
| Molecular Weight | 2946.53 g/mol |
| Exact Mass | 2943.79 |
| IUPAC Name | 5-amino-N-[1-(3,4-dihydro-2H-chromen-8-ylsulfonyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;(5-amino-3,4-dimethylthieno[2,3-c]pyridazin-6-yl)-[3-fluoro-3-(3-methylphenyl)azetidin-1-yl]methanone;5-amino-N-[1-(2-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(3-fluoro-4-methylphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxybenzoyl)azetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[1-(4-methoxyphenyl)sulfonylazetidin-3-yl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide;5-amino-N-[(2-methoxypyrimidin-5-yl)methyl]-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxamide |
| SMILES | COc1ccc(C(=O)N2CC(NC(=O)c3sc4nnc(C)c(C)c4c3N)C2)cc1.COc1ccc(S(=O)(=O)N2CC(NC(=O)c3sc4nnc(C)c(C)c4c3N)C2)cc1.COc1ncc(CNC(=O)c2sc3nnc(C)c(C)c3c2N)cn1.Cc1ccc(S(=O)(=O)N2CC(NC(=O)c3sc4nnc(C)c(C)c4c3N)C2)c(F)c1.Cc1ccc(S(=O)(=O)N2CC(NC(=O)c3sc4nnc(C)c(C)c4c3N)C2)cc1F.Cc1cccc(C2(F)CN(C(=O)c3sc4nnc(C)c(C)c4c3N)C2)c1.Cc1nnc2sc(C(=O)NC3CN(S(=O)(=O)c4cccc5c4OCCC5)C3)c(N)c2c1C |
| InChI | InChI=1S/C21H23N5O4S2.C20H21N5O3S.2C19H20FN5O3S2.C19H19FN4OS.C19H21N5O4S2.C15H16N6O2S/c1-11-12(2)24-25-21-16(11)17(22)19(31-21)20(27)23-14-9-26(10-14)32(28,29)15-7-3-5-13-6-4-8-30-18(13)15;1-10-11(2)23-24-19-15(10)16(21)17(29-19)18(26)22-13-8-25(9-13)20(27)12-4-6-14(28-3)7-5-12;1-9-4-5-13(6-14(9)20)30(27,28)25-7-12(8-25)22-18(26)17-16(21)15-10(2)11(3)23-24-19(15)29-17;1-9-4-5-14(13(20)6-9)30(27,28)25-7-12(8-25)22-18(26)17-16(21)15-10(2)11(3)23-24-19(15)29-17;1-10-5-4-6-13(7-10)19(20)8-24(9-19)18(25)16-15(21)14-11(2)12(3)22-23-17(14)26-16;1-10-11(2)22-23-19-15(10)16(20)17(29-19)18(25)21-12-8-24(9-12)30(26,27)14-6-4-13(28-3)5-7-14;1-7-8(2)20-21-14-10(7)11(16)12(24-14)13(22)17-4-9-5-18-15(23-3)19-6-9/h3,5,7,14H,4,6,8-10,22H2,1-2H3,(H,23,27);4-7,13H,8-9,21H2,1-3H3,(H,22,26);2*4-6,12H,7-8,21H2,1-3H3,(H,22,26);4-7H,8-9,21H2,1-3H3;4-7,12H,8-9,20H2,1-3H3,(H,21,25);5-6H,4,16H2,1-3H3,(H,17,22) |
| InChIKey | FNDUDEVGTOFDGU-UHFFFAOYSA-N |
| XLogP | 15.29 |
| TPSA | 790.04 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 201 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2946.53 |
| LogP ≤ 5 | 15.29 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 50 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158082796 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.